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Abstract
Background: Canine atopic dermatitis (AD) is a common, heritable, chronic allergic skin condition prevalent in the
West Highland White Terrier (WHWT). In canine AD, environmental allergens trigger an inflammatory response
causing visible skin lesions and chronic pruritus that can lead to secondary bacterial and yeast infections. The
disorder shares many of the clinical and histopathological characteristics of human AD and represents an animal
model of this disorder that could be used to further elucidate genetic causes of human AD. Microsatellite markers
genotyped in families of WHWTs affected with AD were used to perform a genome-wide linkage study in order to
isolate chromosomal regions associated with the disorder.
Results: Blood samples and health questionnaires were collected from 108 WHWTs spanning three families. A
linkage simulation using these 108 dogs showed high power to detect a highly penetrant mutation. Ninety
WHWTs were genotyped using markers from the Minimal Screening Set 2 (MSS-2). Two hundred and fifty six
markers were informative and were used for linkage analysis. Using a LOD score of 2.7 as a significance threshold,
no chromosomal regions were identified with significant linkage to AD. LOD scores greater than 1.0 were located
in a 56 cM region of chromosome 7.
Conclusions: The study was unable to detect any chromosomal regions significantly linked to canine AD. This
could be a result of factors such as environmental modification of phenotype, incorrect assignment of phenotype,
a mutation of low penetrance, or incomplete genome coverage. A genome-wide SNP association study in a larger
cohort of WHWTs may prove more successful by providing higher density coverage and higher statistical power.
Background
Canine atopic dermatitis (AD) is a common, heritable,
chronic allergic skin condition that can cause lifelong
morbidity in dogs [1,2]. AD is the ninth most common
disorder diagnosed in veterinary practice [3], and certain
dog breeds such as the West Highland White Terrier
(WHWT), with a prevalence as high as 18.7% [4], are
more susceptible to the condition than others [5]. In
canine AD, environmental allergens such as house dust
mites [6] trigger an inflammatory response leading to the
development of erythematous macules and papular
lesions [7]. Clinical signs usually manifest between six
months and three years of age and the chronic pruritus
associated with AD leads to excessive licking, alopecia,
hyperpigmentation, scaling, lichenification and secondary
bacterial and yeast infections [8]. Diagnosis is based on a
set of general criteria including chronic or chronic-relap-
sing pruritus and dermatitis, classical appearance and dis-
tribution of lesions, and family history or breed
predisposition and elimination of other potential causes
for dermatitis such as parasite infection, flea allergy der-
matitis, or adverse food reactions [9]. There are currently
no laboratory tests that specifically diagnose canine AD
[2]. But secondary criteria used to confirm the diagnosis
of AD include the demonstration of allergen specific IgE
or positive intradermal test to environmental allergens,
as well as response to appropriate clinical therapy with
glucocorticoids [9]. Treatment includes allergen specific
immunotherapy, glucocorticoids and calcineurin inhibi-
tors such as cyclosporine and tacrolimus [2].
Canine AD shares many of the clinical and histopatholo-
gical characteristics of human AD and is a good animal
model for the disease [10] that could prove useful in unco-
vering additional causative genes in humans. The gene for
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1), has had the most consistent association with AD [11]
with two common loss of function mutations initially
identified [12], and additional mutations identified subse-
quently [13]. Filaggrin interacts with intermediate fila-
ments in the cytoskeleton and forms the stratum corneum
of the epidermis [14]. The stratum corneum acts as a bar-
rier and locks in essential fluids such as water [15]. How-
ever, although FLG mutations are associated with human
AD, they do not fully account for the disease [12,13].
Investigation of the orthologous canine gene for FLG,
located on canine chromosome 17 (CFA 17), in a cohort
of WHWTs failed to show linkage to canine AD [16] rais-
ing the possibility that investigation of the cause of AD in
dogs may uncover new candidate genes for the human
condition. The study reported here aimed to identify an
enriched genetic locus linked to AD in our WHWT pedi-
grees by testing for linkage to genetic markers across the
entire genome. The study was unable to detect any chro-
mosomal regions significantly linked to canine AD in
WHWTs using a genome-wide family-based linkage
approach.
Methods
Recruitment and Sample Collection
WHWTs affected with AD were recruited through referral
from veterinary dermatologists and breed clubs across the
United States. Pedigrees were collected and the dogs orga-
nized into families. Health questionnaires and blood sam-
ples were collected from dogs in families containing a
minimum of three generations. All protocols were per-
formed with approval from North Carolina State Univer-
sity’s Institutional Animal Care and Use Committee. The
health questionnaires enquired about each dog’sa g e ,p e d i -
gree, allergies (including specific questions about the diag-
nosis and treatment of skin lesions), as well as any family
history of allergic disease (if applicable). One of the study’s
investigators (TJMO), a board certified veterinary derma-
tologist, determined each dog’s affected status by review-
ing their health questionnaire and any additional collected
information. The diagnosis of AD was made according to
standard methods [2] with fulfillment of all the following
criteria: family history of pruritic skin lesions; juvenile
onset of a pruritic erythematous skin eruption with a char-
acteristic distribution; exclusion of resembling pruritic
skin diseases such as non-atopic food allergies, scabies,
and skin infections according to standard diagnostic and
therapeutic methods; documentation of hypersensitivity
against house dust mites, mold or pollen allergens by
intradermal testing or allergen-specific IgE serology;
response of skin lesions to anti-inflammatory drugs with
evidence of efficacy for treatment of canine AD (e.g. oral
or topical glucocorticoids, oral cyclosporine or topical
tacrolimus). Dogs were considered normal if they reached
four years of age with no evidence of clinical signs of AD.
Dogs that could not definitively be classified as “affected”
or “normal” based on collected information were classified
as of “undetermined” status.
Blood samples were collected into acid citrate dextrose
(ACD) tubes and shipped overnight on ice to the labora-
tory where DNA was extracted using the QIAamp DNA
Blood Mini Kit (Qiagen, Valencia, CA). DNA concentra-
tions were measured using a ND-1000 NanoDrop spec-
trophotometer (Thermo Scientific, Wilmington, DE) and
stored at -80°C before being genotyped.
Power Study
Prior to genotyping, a power study was performed to
determine the ability of our pedigrees to identify a linkage
region containing a recessive locus when considering var-
ious penetrance models. The assumption of a recessive
trait was based on previous work that suggested a domi-
nant trait was unlikely [17]. Two recessive models were
considered. The first involved a highly penetrant mutation
in which an individual had a 98% chance of exhibiting the
disease trait if they were homozygous for the risk allele.
There was also a 1% chance of exhibiting the disease due
to other causes (other loci or environmental factors). The
second model assumed a locus with a smaller effect size;
homozygous individuals had a 20% chance of manifesting
the trait while other genotypes had a 5% chance of doing
so (again reflecting the possibility of other loci or environ-
mental factors). In both cases the frequency of the risk
allele at the causal locus was simulated to be 0.2. Once a
genetic model was determined, genotypes for the causal
locus and three linked markers were generated using the
program “markerdrop” from the Morgan (v.2.8.1) software
package [18]. The true pedigree structure was used as a
template when generating the simulated data. Once the
simulated data was generated, it was analyzed using the
“lm_bayes” program of the Morgan (v.2.8.1) software
package [18]. This program implements a likelihood-based
Markov chain Monte Carlo (MCMC) approach designed
for linkage analyses of large pedigrees containing inbreed-
ing loops, which the program allows to remain intact [19].
The same analysis technique was used for the real data. As
a model-based approach, this analysis tool requires specifi-
cation of the genetic model, including allele frequencies of
the causal locus. For the analysis of the simulated data, as
for the real data, the frequency of the risk allele was set to
0.39, chosen to match the frequency determined in other
recessive canine diseases [20]. To gauge the sensitivity of
the analysis method to incorrect specification of risk allele
frequency, we simulated data using a risk allele frequency
of 0.2, and performed the analysis assuming a frequency of
0.39 (the risk allele frequency in the analysis of the real
data was also assumed to be 0.39, though other values
were also tested). The simulation of data and the
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resulting LOD scores recorded. Power was estimated as
the proportion of runs in which the LOD score achieved
or exceeded a 2.7 significance threshold within the simu-
lated linkage region.
Genotyping
Whole genome linkage analysis was performed using
288 microsatellite primer sets (Invitrogen, Carlsbad, CA,
USA) from the Minimal Screening Set 2 (MSS-2) [21].
In order to perform multiplex PCR, primers were
labelled with one of four fluorescent tags (FAM, VIC,
NED and PET). Reaction conditions for each marker
were optimized for ease of fragment resolution and to
prevent wasted resources. The DNA fragments were
visualized using an ABI 3730xl DNA Analyzer (Applied
Biosystems, Carlsbad, CA, USA) and analyzed using the
GeneMapper v.3.7 software (Applied Biosystems, Carls-
bad, CA, USA). Genotypes not consistent with familial
relationships were removed from further analysis.
Linkage Analysis
Multipoint linkage analysis was performed using the
“lm_bayes” program of the Morgan (v.2.8.1) statistical
software package [18]. The trait was modelled as a dis-
crete trait with dogs of undetermined or unknown phe-
notype assigned a value of unknown.
Chromosomal positions of the heterozygous markers
were determined using the online canine genetic linkage
map at the University of California, Davis Veterinary Geno-
mics Laboratory (http://www.vgl.ucdavis.edu/dogmap/)
and homozygous markers were not included in the linkage
analysis. The trait frequency was set to default at 0.61 for
the common allele and 0.39 for the risk allele and also
altered to assess the effect of different allele frequencies.
Marker allele frequencies were calculated using the Case
Control tests for Samples with Related Individuals (CC-
QLS) [22] and Calculation of Kinship and Inbreeding Coef-
ficients Based on Pedigree Information (KinInbcoef) [23]
programs from Mary Sara McPeek’s website (http://www.
stat.uchicago.edu/~mcpeek/software/index.html). The dis-
ease trait was set to default at 98% penetrance, but was
lowered to 88% and raised to 99% with no significant
changes in the results. LOD scores were calculated for
each family separately and then summed across families.
Appropriate genome-wide LOD score significance thresh-
old using linkage analysis with canine pedigrees was calcu-
lated previously by Gordon et al. [24]. Their results
indicated that a threshold of 2.7 yielded a global type-I
error of 5% and thus LOD scores greater than 2.7 were
considered significant in this study. When chromosomal
regions with positive LOD scores were identified, haplo-
types of microsatellites in these regions were compared in
affected and normal dogs for segregation of homozygosity
with affected phenotype. The UCSC Genome Browser
(http://genome.ucsc.edu/cgi-bin/hgGateway) was also used
to search for candidate genes previously associated with
AD in these regions.
Results
Sample collection and pedigree analysis
Health questionnaires and pedigrees were collected on
180 related WHWTs. Blood samples were obtained
from 108 of these dogs (30 affected, 50 normal, and 28
of undetermined status) including 41 males and 67
females. Using the pedigree information from these
WHWTs, three family groups were formed with a mini-
mum of three generations between groups. The smallest
of the three families contained nine dogs and the largest
family contained 121 dogs. The genotyped WHWTs (22
affected, 40 normal, and 28 of undetermined status) ran-
g e di na g ef r o m1t o1 6y e a r s ,a n dt h ea v e r a g ea g eo f
affected dogs was 6 years (range 1 year to 13 years) and
of normal dogs was 9 years (range 4 years to 16 years).
Power Study
In the simulations for which a highly penetrant gene
was generated, a LOD score equal to or greater than 2.7
was detected in 100% of the simulation runs, with a
maximum score of 7.5 (Figure 1A). For a gene with low
penetrance, none (0%) of the simulation runs resulted in
a LOD score equal or greater than 2.7, the maximum
being 2.6 (Figure 1B).
Genotyping and Linkage Analysis
Seventy-five WHWTs, spanning the three families were
genotyped using the MSS-2 microsatellite makers [21].
Additional dogs were genotyped when preliminary analysis
gave positive LOD scores in a region, resulting in 90 of the
108 WHWTs being genotyped on some of the markers. Of
the 288 microsatellite markers genotyped, 32 were homo-
zygous and discarded and the remaining 256 were used
for linkage analysis. These 256 markers covered the gen-
ome with an average inter-marker distance of 8.59 cM,
with the largest inter-marker distance being 37.6 cM on
CFA 7.
The highest LOD score via linkage analysis was 1.25 on
CFA 7, while all other chromosomes had scores less than
0.5. CFA7’s peak LOD scores were located between mar-
kers FH3972 and FH2973 and spanned approximately 56
cM. Repeated analysis with alteration of both penetrance
and risk allele frequency did not result in improved LOD
scores.
None of the haplotypes showed segregation between
affected and normal dogs in the 56 cM region on CFA
7, but the region did contain the gene for S100 calcium
binding protein A8 (S100A8), one of the units of the cal-
protectin complex present in epidermal cells [25]. This
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previously [26-28].
Discussion
This report describes a genome-wide linkage study of
canine AD in which no chromosomal regions showed
significant evidence for linkage. Genome-wide linkage
studies using microsatellites have been a useful tool
employed to map disease loci in dogs [29-31] however,
their power can be limited in complex traits and in dis-
eases where phenotype is difficult to confirm [32]. Our
simulations verified that our linkage study had excellent
power to detect a highly penetrant mutation. The failure
to identify such a locus could suggest that the inheritance
Figure 1 Power of trait detection. Simulations to determine the power to detect a highly penetrant mutation (A) and a mutation of low
penetrance (B). The bold horizontal line indicates a LOD score of 2.7, bottom bar between the triangles signifies a mutation segregating with
AD and the triangles represent locations of microsatellite markers.
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is the case in human AD, which has been described as
multifactorial and polygenic with a non-Mendelian mode
of inheritance [33]. However, linkage analysis has been
used in canine epilepsy in which a recent genome-wide
linkage scan in Belgian shepherd dogs identified six loci
suggesting association with idiopathic epilepsy, a disease
of presumed polygenic mode of inheritance with a reces-
sive gene of major influence [34].
The mode of inheritance of canine AD has been inves-
tigated in different breeds but a precise mode of inheri-
tance has not been established [16,17,35,36]. We
attempted to determine the mode of inheritance using
information on complete WHWT litters from normal
parents, yet were extremely limited by the difficulty in
obtaining detailed phenotypic information on complete
litters. Enumeration of affected and normal dogs in
seven complete litters did suggest a major recessive
genetic influence. Due to the controlled breeding prac-
tices used to generate and perpetuate dog breeds, single
gene effects can be enriched within one breed or family,
allowing their detection with linkage analysis. However,
this proved not to be the case with the WHWT pedi-
grees we worked with.
Genome-wide association studies (GWAS) using single
nucleotide polymorphisms (SNPs) are an increasingly
popular approach used to identify genetic mutations
involved in complex diseases. A GWAS performed in
Golden Retrievers with AD identified two SNPs asso-
ciated with AD located in intronic regions [37]. A
further study by the same group to evaluate SNPs in
AD candidate genes was performed in Golden Retrievers
and seven other dog breeds including the WHWT [38].
A SNP was identified in the thymic stromal lymphpoie-
tin receptor (TSLPR) gene that was associated with AD
in all eight breeds as well as a SNP in FLG associated
with AD in UK Labradors. Results of this study suggest
that different breeds, as well as dogs of the same breed
from different geographic regions have different genetic
risk factors for AD [38]. As we did not genotype mar-
kers on the X chromosome, we cannot exclude the pos-
sibility of linkage to a region including TSLPR in our
WHWT family.
Although a specific chromosomal region linked to AD
in WHWTs was not identified, we were able to exclude
linkage to the FLG locus, corroborating the results of
other studies [16,38].
Linkage could not be ruled out in a 56 cM region on
CFA 7. The gene S100A8, located within this 56 cM
region on CFA 7, has been reported to play a role in
canine AD [27,28]. Members of the S100 family are pro-
inflammatory molecules released by phagocytes [39] and
also keratinocytes (epidermal cells) [40] and are present
in the human epidermal differentiation complex (EDC)
which has been both linked to and shown association
with AD in humans [41]. The three microsatellite mar-
kers genotyped in the region were separated by 37.6 and
18.7 cM. Genotyping of additional markers in this 56
cM region may definitively rule-out linkage in the
region.
Determination of phenotype may also have influenced
the results of our study. Affected dogs were diagnosed by
one veterinary dermatologist (TJMO) using stringent cri-
teria thereby enhancing the chance of homozygous diag-
noses. However, the assignment of normal phenotype is
more likely to represent a source of error; it is possible
that dogs classified as normal had minimal or seasonal
symptoms that were missed by their owners and veteri-
narians. It is also possible that an apparently normal dog
may not have experienced (and possibly never will) the
relevant allergenic triggers. While this is a source of con-
cern, normal phenotype was assigned only to dogs older
than four years of age and when possible, owners were
re-contacted to confirm that there was no change in
affection status over the course of the study which
spanned several years. Since AD is usually diagnosed
before the age of three, this approach limited erroneous
identification of normal dogs.
Finally, although the MSS-2 set of microsatellites pro-
vides markers across the entire canine genome, homo-
zygosity of some markers in our population of dogs
meant that some regions were not covered at high den-
sity. A GWAS in a larger cohort of WHWTs may prove
more successful by providing higher density coverage of
the entire genome and higher statistical power.
Conclusions
A genetic locus linked to AD in WHWTs was not iden-
tified. This could be a result of factors such as environ-
mental modification of phenotype, incorrect assignment
of phenotype, a mutation of low penetrance, or incom-
plete genome coverage.
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